RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp Builds European Market Presence, page-3

  1. Dhm
    2,381 Posts.
    lightbulb Created with Sketch. 3493
    More clinical trials. Surely they could impliment on the back of CE Marking - what use is the approval if hospitals need further proof.
    Anyway, still good news though.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.